Recent studies have illustrated that EIF4A3 is upregulated in different cancers, including hepatocellular carcinoma (HCC), glioblastoma, pancreatic cancer and CRC (Ye et al. 2021). This evidence concerns the gene EIF4A3 and hepatocellular carcinoma.